Rocket Lab's Stock Plunge Defies $2.2 Billion Backlog and Military Nod

Rocket Lab's rapid launches and revenue surge fail to halt a 40% stock selloff as investors question its $51.7B valuation without a firm Pentagon contract.

Rocket Lab has never been busier. The company is rolling out an Electron rocket every 11 days, bagged 31 new launch contracts in the first quarter, and now sits in an exclusive supplier pool for a multibillion-dollar U.S. Space Force surveillance program. Yet investors are heading for the exits with equal velocity. The stock lost more than 10% on Wednesday alone, closing at $85.41, and has surrendered over 40% in the past 30 sessions.

The military vote of confidence came through the Space Force's SB-AMTI program — a satellite-based tracking system designed to monitor airborne threats worldwide. Rocket Lab joins Lockheed Martin and L3Harris as potential providers after SpaceX snagged the first contract, worth $4.16 billion. But no actual deal has been awarded to Rocket Lab yet, and the market is demanding more than a seat at the table.

Operationally, the company is demonstrating exactly the kind of speed the Pentagon values. During the recent VICTUS HAZE mission, completed on June 22 for the U.S. Space Force Space Systems Command, an Electron rocket lifted off just 16 hours and 42 minutes after the order came in — more than ten hours faster than the previous rapid-response record. The Pioneer satellite was mission-ready 37 hours and 36 minutes later, slicing more than 34 hours off the 72-hour deadline. Rocket Lab's vertical integration — propulsion, solar panels, reaction wheels, radios, star trackers, structures, and flight software all built in-house — makes that repeatability possible.

The financial narrative supports the growth story, at least on the top line. First?quarter 2026 revenue hit $200.3 million, a 63.5% year?over?year surge, while the net loss narrowed to $45.0 million. The backlog swelled to $2.2 billion, up roughly 20% from the prior quarter, and the company has more than 70 contracted missions on its manifest, including five dedicated Neutron launches. Management is guiding for second?quarter revenue between $225 million and $240 million. Cash on hand exceeds $1.2 billion.

None of that has been enough to halt the selloff. The stock has fallen for four consecutive days and sits 43% below the 52?week high of $151.00 reached on May 27. The 30?day annualized volatility stands at a punishing 101%, and the relative strength index has dropped to 36, territory that technicians label oversold. On a longer time frame the picture is less dire: shares remain up 164% year?to?date and are still 12% above the 200?day moving average, meaning the secular uptrend is intact even if the near?term damage is severe.

The disconnect boils down to valuation. Rocket Lab carries a market capitalization of roughly $51.7 billion, a multiple that the market is now questioning in the absence of a concrete Pentagon contract. Analysts remain broadly bullish, with an average price target of $102.76 implying upside of about 20%, but the stock needs catalyst in hand, not just on the horizon. The next test comes with the upcoming Electron mission for Japanese customer iQPS, scheduled for June, and the second?quarter earnings report, where investors will scrutinize whether the production cadence and backlog growth actually translate into the guided revenue range. Until the Space Force money flows, Rocket Lab's operational tempo may continue to run far ahead of its share price.